Checkpoint Therapeutics Investor Relations Material
Latest events
Q1 2025
13 May, 2025
Q4 2024
28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Checkpoint Therapeutics Inc
Access all reports
Checkpoint Therapeutics Inc. is a biopharmaceutical company focused on developing immunotherapy and targeted treatments for cancer. The company specializes in monoclonal antibodies and small-molecule inhibitors designed to enhance the immune system’s ability to fight tumors. Its pipeline includes drug candidates for various cancers, advancing through clinical trials and regulatory approvals. The company is headquartered in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Checkpoint Therapeutics Inc
Corporate Presentation
Checkpoint Therapeutics Inc
Corporate Presentation
Checkpoint Therapeutics Inc
Latest articles
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
Ticker symbol
CKPT
Country
🇺🇸 United States